PRN Medicines Management for Older People with Long-Term Mental Health Disorders in Home Care by Mojtaba, Vaismoradi
R E V I E W
PRN Medicines Management for Older People 
with Long-Term Mental Health Disorders in 
Home Care
Mojtaba Vaismoradi 1 
Shazia Jamshed2 
Stefan Lorenzl3,4 
Piret Paal 5
1Faculty of Nursing and Health Sciences, 
Nord University, Bodø, 8049, Norway; 
2Clinical Pharmacy and Practice, Faculty 
of Pharmacy, University Sultan Zainal 
Abidin, Terengganu, 22200, Malaysia; 
3Professorship for Palliative Care, Institute 
of Nursing Science and -Practice, 
Paracelsus Medical University, Salzburg, 
5020, Austria; 4Department of Neurology, 
Klinikum Agatharied, Hausham, 83734, 
Germany; 5WHO Collaborating Centre at 
the Institute for Nursing Science and 
Practice, Paracelsus Medical University, 
Salzburg, A-5020, Austria 
Abstract: Older people with long-term mental health conditions who receive care in their 
own home are vulnerable to the inappropriate use of medications and polypharmacy given 
their underlying health conditions and comorbidities. Inappropriate use of pro re nata (PRN) 
medications in these older people can enhance their suffering and have negative conse-
quences for their quality of life and well-being, leading to readmission to healthcare settings 
and the increased cost of health care. This narrative review on published international 
literature aims at improving our understanding of medicines management in home care 
and how to improve PRN medication use among older people with long-term health condi-
tions in their own home. Accordingly, the improvement of PRN medicines management for 
these older people requires the development of an individualised care plan considering 
‘reduction of older people’s dependence on PRN medications’, ‘empowerment of family 
caregivers’, and ‘support by healthcare professionals.’ PRN medication use should be 
reduced through deprescription and discontinuation strategies. Also, older people and their 
family caregivers should be encouraged to prioritize the use of non-pharmacologic methods 
to relieve physical and psychological problems. Besides the empowerment of family care-
givers through role development, education and training about PRN medications, and 
involvement in decision-making, they need support by the multidisciplinary network in 
terms of supervision, monitoring, and home visits. 
Keywords: family caregiver, home care, medication, medicines management, mental health, 
older people, patient safety, pro re nata, PRN
Introduction
Long-term mental health conditions consist of various disorders characterised by 
abnormal thoughts, cognition, perceptions, emotions, behaviours, and relationships 
with others that cause long-term suffering and disability.1 It has been reported that 
the risk of developing long-term mental health disorders especially cognitive dis-
orders and depression among older people, as aged above 60 years, is higher than 
other age groups; for instance, 15% of older adults suffer from a mental disorder.2 
Also, about 50%, 10%, and 17% of older people suffer from cognitive disorders, 
anxiety, and depression, respectively.3,4
The appropriate use of medications consisting of antidepressants, anti-anxiety, 
stimulants, antipsychotics, and mood-stabilisers have been recognised to have 
a crucial role in the treatment of long-term mental health disorders.5,6 About 70% 
of older people are prescribed at least one psychotropic medication, but the 
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increased prescription of psychotropic medications and 
benzodiazepines has been associated with a reduced qual-
ity of life.7
Opioids, anticoagulants, and antipsychotics are high-risk 
medications in the medication regimen of these older people 
despite their benefits.8 The total exposure of older people to 
medications including anticholinergic and sedatives is asso-
ciated with a higher risk of hospital stays.9 The prevalence 
of potentially inappropriate medications for older people 
with long-term mental health conditions with the presence 
of polypharmacy ranges from 53.2% to 89.8%.10
The prevention of mortality and morbidities among 
older people with long-term mental health conditions 
requires the reduction of complexity of the medication 
regimen as well as the improvement of medicines manage-
ment in terms of the reduction of prescribed and nonpre-
scribed medication use and avoiding polypharmacy.11,12 
This narrative review on published international literature 
aims at improving our understanding of medicines man-
agement in home care and how to improve PRN medica-
tion use among older people with long-term health 
conditions in their own home.
Concerns Over Medicines 
Management in Home Care
Medicines management in home care also is accompanied 
with many concerns affecting the safety of the medication 
process and quality of life in older people with chronic and 
long-term mental health conditions and their family 
caregivers.
Increasing the total number of medications in these 
older adults has enhanced the risk of potentially inap-
propriate medications between 2 and 10 times.13 
Polypharmacy (5–9 medications) and excessive polyphar-
macy (≥10 drugs) have been observed in 39% and 23% of 
older people receiving home care, respectively.14 The use 
of psychotropic medications including antidepressants and 
other anxiolytic/sedative-hypnotics and benzodiazepines 
by older people in community and primary healthcare 
has increased, which has created concerns about appropri-
ate medication use.15,16
The home medication review for about 80% of older 
people in home care indicates discrepancies with the elec-
tronic medical records.17 The overall prevalence of poten-
tially inappropriate prescribing in older people in home 
care has been reported to be 10–38%,18–20 which has been 
associated with polypharmacy (OR=5.4).18,19
Complexity of medication regimen (OR= 1.22) and 
number of medications (OR= 1.07) in older people living 
in own home are associated with unplanned readmissions 
and hospitalizations.21,22 A nation-wide research in 
Sweden showed that the use of psychotropics and antiepi-
leptic medications was associated with 
institutionalization.23 Also, polypharmacy (OR=2.30) and 
excessive polypharmacy (OR=4.97) have been shown to 
be associated with frailty among older adults.24 Therefore, 
the medication regimen, adverse drug reactions, and side 
effects of prescription and non-prescription medications in 
home care should be carefully assessed given the suscept-
ibility and frailty of older adults with chronic health con-
ditions including mental health disorders living in their 
own home.25
PRN Medicines Management in 
Home Care
Pro re nata (PRN) medications management is the admin-
istration of prescribed medications based on patients’ needs 
instead of administration in predetermined times.26,27 It is 
commonly used for various types of medications to relieve 
patients’ physical and psychological suffering. Besides 
acetaminophen and opioids for pain relief,28 psychotropic 
and psycholeptic medications are more commonly pre-
scribed and administered as PRN to older patients with 
long-term mental health conditions,29–32 but the clinical 
effectiveness of this style of medication use in comparison 
with other prescription and administration styles of medica-
tion has remained unexplored and needs further research.33
Inappropriate use of PRN medications can extend the 
duration of hospitalisation in long-term healthcare settings 
and hinder the smooth transition of care for older people 
with chronic health conditions to their own home. Older 
people with five and more PRN prescriptions have the length 
of stay 4.8 ± 4.3 years in the nursing home.32,34 PRN 
medicines management for psychotropic medications’ use 
by older people with long-term health conditions in their 
own home has remained underreported.35,36 However, issues 
with the use of prescribed and PRN psychotropic medica-
tions among this vulnerable group of patients have been 
reported including the reason for administration (55–81%), 
response to medications (47–92%), and the possibility of use 
of nonpharmacologic interventions instead of medications 
(64–69%).37 It has been stated that older adults in the age 
range of 60–80 years take an average of 10 different pre-
scription and non-prescription medications including PRN.38 
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PRN analgesics are commonly used (50%) by older people 
living in their own homes.25 Polypharmacy with five or more 
long-term drugs (OR= 2.1) is associated with a higher num-
ber of PRN medication use.34 Moreover, the highest cost of 
medication is attributed to psychotropic and neuroleptic 
medications.39 Therefore, improvement of the quality, safety, 
and cost-effectiveness of medication therapy should be the 
centre of attention by healthcare professionals who are 
involved in serving older people with long-term mental 
health conditions in home care.
Initiatives to Safeguard PRN 
Medicines Management in Home 
Care
Older people with long-term mental health conditions living 
in their own home need assistance in the management of 
medications.40 They need individualised and goal-oriented 
care aligned to their needs with the concentration on the 
identification and reduction of the risk of harm.41 
Individualised care planning through the appropriate pre-
scription of medications, rectification of negative attitudes 
and barriers to medicines management including changes in 
lifestyle patterns, and assistance with the medication process 
can improve their adherence to the medication’s regimen as 
well as improve care outcomes.42–44 In this respect, the 
improvement of PRN medicines management in home care 
for older people with long-term mental health conditions 
requires developing an individualised care plan considering 
“reduction of older people’s dependence on PRN medica-
tions”, “empowerment of family caregivers in care”, and 
“support by healthcare professionals.” (Figure 1).
Reduction of Older People’s Dependence 
on PRN Medications
Older people with long-term mental health conditions need 
discontinuation and deprescribing programmes for the 
chronic and sometimes unnecessary use of medications 
with the consideration of the possibility of relapse and 
Figure 1 Improvement of PRN medicines management in home care. PRN stands for pro re nata.
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probable negative consequences on their well-being and 
quality of life.38,45
Deprescribing as the process of tapering or stopping 
medications to tackle the problem of polypharmacy in 
older adults consists of the following five steps:
● Medication review and ascertaining reasons for tak-
ing each medication;
● Calculation of the risk of medication-related harm 
and possibility of deprescribing;
● Assessment of the potential benefits and harm of 
deprescribing for each medication;
● Prioritizing medications with the lowest benefit-harm 
ratio and adverse withdrawal reactions;
● Implementation of the discontinuation program and 
monitoring its positive and negative effects.46,47
This process should be individualised based on cognitive 
and functional abilities and comorbidities of each older 
adult along with the application of close monitoring,48,49 
given that some older people are open to deprescribing and 
prefer to play an active role in related decision making, but 
some others may defer it to their healthcare provider 
because of lack of knowledge.50 Moreover, the success 
of this program depends on the determination of achiev-
able goals and appropriate time planning as well as the 
creation of psychological preparation in older people.
Stepwise deprescribing interventions for benzodiaze-
pines through pharmacological substitution, psychological 
support, cognitive-behavioural therapy, education, shared 
decision making by the pharmacist, physician and older 
people have been shown to be effective in dose reduction 
and discontinuation between 27% and 80% of cases.48,51,52 
Also, discontinuation of neuroleptic medications has been 
shown to have no detrimental effect on functional and 
cognitive status of older people with long-term mental 
health conditions.53
Reduction of antipsychotic medications’ use by the 
older people and prevention of its negative consequences 
on their health and well-being requires the facilitation of 
access to non-pharmacological methods including psy-
chotherapy, social interventions, cognitive behavioural 
therapy, and psychoeducation.54–56 The effectiveness of 
psychological and cognitive treatments in reducing the 
symptoms and suffering of older people with long-term 
mental health conditions have been shown.57–59 Also, they 
have been shown to have better effects on relieving the 
symptoms of these older people than pharmacotherapy.60 
Nonpharmacological and psychosocial interventions such 
as improving the home environment condition by family 
caregivers have been shown to reduce the frequency and 
severity of behavioural and psychological symptoms in 
older adults with an effect size equal to 
pharmacotherapy.61
In addition, alternative and complementary medicine 
including aromatherapy, massage, meditation, and music 
therapy with the consideration of their acceptability by the 
older people and their family caregivers as well as after 
balancing their benefits and harm can be used to improve 
the toleration of discontinued psychotropic medications 
and reduce the need to medication therapy.62–64
Empowerment of Family Caregivers
Home care initiatives should concentrate on the encour-
agement of older people to remain independent as much as 
possible.65 However, the progression of cognitive and 
mental health issues negatively influences the older peo-
ple’s ability to follow up medicines management’s inter-
ventions in terms of planning, organising, and 
implementing tasks, which enhances the risk of harm and 
non-adherence to medications and consequently readmis-
sion to the hospital and dependence on family 
caregivers.66 Provision of home care to older people who 
have chronic and advanced illnesses greatly impacts on the 
realm of the family caregiver who are often a spouse or 
child. Although family caregivers’ involvement in the 
medication process can improve medication safety for 
older people with mental health issues,67 it imposes 
a significant amount of stress and burden of care on 
them.68–71 Family caregivers even suffer from mental ill-
ness and care burden may even induce depression among 
them.72
Lack of monitoring device in home care and inability 
to assess warning signs in older people are barriers to safe 
medicines management by family caregivers.73 
Medication management skills by family caregivers as 
the appropriate identification of symptoms in older people 
and the administration of PRN medications accordingly 
are required to enhance the appropriate use of medications 
and prevent over and under medication use.74 Family 
caregivers should be empowered to be involved in shared 
decision making that helps with developing an individua-
lized programme for the appropriate prescription of med-
ications with the consideration of older people’s medical 
needs, functional abilities, and well-being.75 In this 
respect, training and education of family caregivers for 
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the management of symptoms and behaviours, what poten-
tially can trigger psychological issues in older people with 
long-term mental health conditions, and medication ther-
apy based on the older people’s needs supports appropriate 
medication use in home care.76–78 Family caregivers need 
to build therapeutic relationships with healthcare profes-
sionals to negotiate care, play an active role in care, and be 
able to manage their role expectations in home care.79
Support by Healthcare Professionals
Older people with long-term mental health conditions and 
their family caregivers need support and supervision in 
home care, but they mostly have no access to related 
services or cannot use them.80 An early access to palliative 
care services is of particular importance with a focus on 
treatment and provision of support both for older people 
and their family caregivers. Physical and emotional symp-
toms of care burden should be regularly assessed to avoid 
somatic comorbidities, reduce frequent hospital admis-
sions, and ameliorate the low quality of home care.81 
Support provided by physicians, nurses, pharmacists, and 
social workers can mediate resilience and burden of care 
in home care.82
Supervision by healthcare professionals encompasses 
reviewing medication use in home care, rationalizing 
unnecessary medications and PRN medicines manage-
ment, and provision of as needed monitoring and 
referrals.83–85 Provision of medication services to older 
people in home care by healthcare staff including pharma-
cists can reduce the medication-related hospitalization rate 
(36%) and $6.6 million in healthcare cost.86
The application of explicit screening instruments for 
conducting medication reviews aiming at identifying 
unmet medication needs can significantly improve appro-
priate medication use.87 For instance, STOPP (Screening 
Tool of Older Persons’ Prescriptions) and START 
(Screening Tool to Alert doctors to Right, ie, appropri-
ate, indicated Treatment) can be used by healthcare pro-
fessionals to appraise the appropriateness of medication 
prescriptions for older people in the context of his/her 
concurrent diagnoses and to be effective in reducing fall 
incidents, readmission to the healthcare settings, medica-
tion omissions, and medication costs.88–91 Also, the 
execution of “NO TEARS” tool: Need and indication; 
Open questions; Tests and monitoring; Evidence and 
guidelines; Adverse events; Risk reduction or preven-
tion; Simplification and switches92 can provide an effi-
cient medication review in a 10-minute consultation 
using audio-visual links. It serves as appropriate check 
Table 1 Strategies and Interventions for PRN Medicines Management in Home Care
Improvement Strategies Practical Interventions
Reduction of older people’s dependence 
on PRN medications
Assessment of the older people’s and their family caregivers’ needs to PRN medications; 
Consideration of the impact of discontinuation and deprescription on the older people’s physical and 
psychological health, and cognitive and functional abilities; Development of an individualised, stepwise 
and realistic plan for medication discontinuation and deprescription; Encouragement of the older 
people and their family caregivers to use non-pharmacologic, and complementary and alternative 
medicine methods
Empowerment of family caregivers in care Consideration of the stress and burden of care on family caregivers; Education and training about 
medicines management skills and symptoms indicating the appropriate use of medications; Role 
expansion and involvement of family caregivers in decision making initiatives regarding medications; 
Building close therapeutic relationships between family caregivers and healthcare professionals;
Support by healthcare professionals Facilitation of access to palliative and supportive home care; Continuous assessment of the symptoms 
of care burden; Development of the multidisciplinary network of home care consisting of physicians, 
nurses, pharmacists, and social workers; Frequent medication review and the rationalisation of 
medication use; Application of screening instruments for identifying needs to medications; Virtual and 
in-person home visits for monitoring the use of medications; Provision of education, consultation, 
decision support, problem-solving, and clinical care; Data collection and sharing between healthcare 
professionals in various healthcare settings during transition of care
Notes: A guideline is needed to help with the selection of best medication for PRN use, its dosage, frequency, and administration method in home care. Also, more original 
research should be carried out to identify barriers to and the facilitators of appropriate PRN medicines management in home care including relationships between older 
people and family caregivers, cooperation with healthcare professionals in home care, as well as dependence on medications especially opioids. Additionally, the effectives of 
interventions aiming at the reduction of related issues and improvement of medication safety in home care should be studied.
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and balance measure for prescribed and PRN medica-
tions at home and can minimize caregiver’s fatigue.
Telehealth services including virtual home visits consist-
ing of the use of audio-visual communication devices such 
as videoconference and videophones in a daily manner and 
in combination with in-person visits as low-cost and feasible 
supervision methods can support families with medicines 
management and improve appropriate medication use by 
the older people in home care.93–95 Also, technology has 
been recognised as an appropriate platform for education, 
consultation, decision support, problem-solving, social sup-
port, monitoring the healthcare condition, and even delivery 
of clinical care such as assistance with medication dispen-
sing and administration aiming at the enhancement of the 
quality of medication process by family caregivers.45,96
The development of a multidisciplinary care programme 
through organising a network linking healthcare specialists 
including community pharmacist, geriatrician, and commu-
nity nurse that supports family caregivers with pharmacologi-
cal and psychosocial treatments in home care as well as collect 
and share information between healthcare professionals to 
optimize managing the complex medication regimen is one 
part of monitoring and supervision in home care.97–99
Conclusion
There is a need to pay more attention to the safety of the 
medication process in home care and explore factors that 
cause over-prescription of medications and polypharmacy 
influencing the safety of older people with long-term 
mental health condition in home care.
Healthcare professionals in the multidisciplinary 
healthcare team should assess and monitor the use of 
prescribed, non-prescribed, and PRN medications in 
home care and develop individualised programmes for 
PRN medicines optimisation (Table 1).
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